These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21331995)

  • 1. Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome.
    Yener O; Aksoy F; Demır M; Özçelık A; Erengül C
    Turk J Gastroenterol; 2010 Dec; 21(4):411-5. PubMed ID: 21331995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
    García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
    Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease.
    Yilmaz Y; Ayyildiz T; Akin H; Colak Y; Ozturk O; Senates E; Tuncer I; Dolar E
    Gut Liver; 2014 May; 8(3):313-7. PubMed ID: 24827629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
    Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy.
    Ahmed F; Baloch Q; Memon ZA; Ali I
    Ann Med Surg (Lond); 2017 May; 17():7-13. PubMed ID: 28377802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent non-alcoholic fatty liver disease-a clinical-histological study.
    Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
    J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).
    Hossain N; Stepanova M; Afendy A; Nader F; Younossi Y; Rafiq N; Goodman Z; Younossi ZM
    Scand J Gastroenterol; 2011 Apr; 46(4):479-84. PubMed ID: 21114431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
    Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
    Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM
    Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.
    Ruhl CE; Everhart JE
    Am J Gastroenterol; 2013 Jun; 108(6):952-8. PubMed ID: 23545713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Non-Alcoholic Steatohepatitis on Histopathology in Patients of Type 2 Diabetes Mellitus with Duration of More than 5 Years.
    Seetlani NK; Memon AR; Tanveer S; Ali A; Ali P; Imran K; Haroon H
    J Coll Physicians Surg Pak; 2016 Aug; 26(8):643-6. PubMed ID: 27539754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?
    Nervi F; Arrese M
    Am J Gastroenterol; 2013 Jun; 108(6):959-61. PubMed ID: 23735917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients.
    Bahrami H; Daryani NE; Mirmomen S; Kamangar F; Haghpanah B; Djalili M
    BMC Gastroenterol; 2003 Oct; 3():27. PubMed ID: 14561231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease].
    Roesch-Dietlen F; Pérez-Morales A; Melo-Santisteban G; Díaz-Blanco F; Martínez-Fernández S; Martínez JA; Cid-Juárez S
    Cir Cir; 2008; 76(1):37-42. PubMed ID: 18492418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.